{"Bristol-Myers Squibb":{"RelatedTo":"Resource:EFPIA","Synonym":["Bristol-Myers Squibb Company","Bristol Myers Squibb"],"Related disease":["Cancer","HIV","AIDS","Cardiovascular disease","Diabetes","Hepatitis","Rheumatoid arthritis"],"CurationStatus":"uncurated","Address":["Bristol-Myers Squibb","Corporate Headquarters","345 Park Avenue","New York"],"SuperCategory":"Commercial Organization","Id":"nlx_158087","Species":"Human","Keywords":["Drug","Pharmaceutical","Medicine","Neuroscience","Virology","Immunology","Bristol Myers Squibb EMEA sarl","Bristol-Myers Squibb EMEA"],"DefiningCitation":"http:\/\/www.bms.com\/","Abbrev":["BMS"],"Definition":"A global biopharmaceutical company that develops and manufactures prescription pharmaceuticals in several therapeutic areas, including cancer, HIV\/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders. BMS' primary R&D sites are located in Princeton, New Jersey (formerly Squibb) and Wallingford, Connecticut (formerly Bristol-Myers), with other sites in Hopewell and New Brunswick, New Jersey, and in Braine-l'Alleud, Belgium, Tokyo, and Bangalore, India. (Adapted from Wikipedia)"}}